tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Joon Lee, 222 are a BUY (89.16%), 27 are a HOLD (10.84%).
Analyst Joon Lee, currently employed at TRUIST, carries an average stock price target met ratio of 51.44% that have a potential upside of 63.23% achieved within 268 days.
Joon Lee’s has documented 489 price targets and ratings displayed on 30 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on VRTX, Vertex Pharmaceuticals at 11-Mar-2026.
Analyst best performing recommendations are on CORT (CORCEPT THERAPEUTICS).
The best stock recommendation documented was for CORT (CORCEPT THERAPEUTICS) at 8/2/2023. The price target of $29 was fulfilled within 1 day with a profit of $3.99 (15.95%) receiving and performance score of 159.54.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 30-Apr-2024
$5
$0.64 (14.68%)
11 months 11 days ago
(17-Nov-2025)
0/5 (0%)
$0.73 (17.10%)
Buy Since 01-Nov-2023
$5.5
$1.14 (26.15%)
$12
11 months 29 days ago
(29-Oct-2025)
1/7 (14.29%)
$1.27 (30.02%)
292
Hold Since 16-Apr-2025
$4
$-0.36 (-8.26%)
$5
1 years ago
(28-Oct-2025)
1/2 (50%)
$-0.26 (-6.10%)
168
Buy Since 18-Jul-2024
1 years 2 months 15 days ago
(13-Aug-2025)
2/3 (66.67%)
$30.52 (321.94%)
1046
Hold Since 19-Mar-2024
$4
$-0.36 (-8.26%)
$5
1 years 5 months 13 days ago
(15-May-2025)
4/6 (66.67%)
$1.95 (95.12%)
205
What Year was the first public recommendation made by Joon Lee?
